Kala Pharmaceuticals
KALA
$6.88
Share price
0.88%
Change (1 day)
-54.71%
Change (1 year)
Categories
Kala Pharmaceuticals (KALA) - Cash on Hand
Cash on Hand as of December 2023 : $50.89 M
According to Kala Pharmaceuticals's latest financial reports the company has $50.89 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Kala Pharmaceuticals - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $70.49 M | -23.49% |
| 2021-12-31 | $92.13 M | -39.99% |
| 2020-12-31 | $0.15 B | 79.69% |
| 2019-12-31 | $85.44 M | -50% |
| 2018-12-31 | $0.17 B | 49.17% |
| 2017-12-31 | $0.11 B | 151.95% |
| 2016-12-31 | $45.47 M | 689.58% |
| 2015-12-31 | $5.75 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | 88.39% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -59.09% | 🇺🇸 USA |